Accepting applications until August 1

City of Hope Intensive Course in Genomic Cancer Risk Assessment

Accepting applications until August 1

Contribution of Risk Factors, Including Polygenic Score, to the Multifactorial Risk Assessment for the Implementation of Personalized Breast Cancer Screening: Insights from the PERSPECTIVE: Integration and Implementation Project

Xin Yang, Juliet A Usher-Smith, Kristina M Blackmore, et al.

Risk-based breast cancer (BC) screening can provide tailored recommendations based on individual risk. We estimated 10-year BC risks in 3753 women aged 40-70 with no cancer history. The primary endpoint was risk reclassification,... Read More

A systematic review of economic burden of colorectal cancer

Abdosaleh Jafari, Fatemeh A Hosseini, Faride S Jalali et al.Health Sci Rep. 2024 Aug 21;7(8):e70002

Colorectal cancer is the third most common cancer in the Western Hemisphere. It is the third most common cancer in men after prostate and lung cancers and the second most common cancer in women after breast cancer. The data from 3... Read More

A Systematic Review of The Economic Burden of Colorectal Cancer

Aug.Abdosaleh Jafari, Fatemeh A Hosseini, Faride S Jalali et al. Health Sci Rep. 2024 Aug 21;7(8):e70002

Colorectal cancer is the third most common cancer in the Western Hemisphere. It is the third most common cancer in men after prostate and lung cancers and the second most common cancer in women after breast cancer. According to so... Read More

Increased healthcare costs by later stage cancer diagnosis

November McGarvey, Matthew Gitlin, Ela Fadli,and Karen C. Chung. BMC Health Services Research (2022) 22:1155

Cancer represents a significant source of disease burden in the United States (US), both clinically and economically. Diagnosis and treatment of cancer at earlier stages may reduce this burden. To better understand potential impac... Read More

Cost of cancer management by stage at diagnosis among Medicare beneficiaries

Sheila R. Reddy, Michael S. Broder, Eunice Chang et al. Current Medical Research and Opinion. Volume 38, Pages 1285-1294 2022

We used 2012–2016 data from the Surveillance, Epidemiology, and End Results (SEER) registry-Medicare claims database to examine cost of care among Medicare beneficiaries with a confirmed cancer diagnosis. From 2012 to 2016, we ide... Read More

Germline Genetic Testing After Cancer Diagnosis

Allison W Kurian, Paul Abrahamse, Allison Furgal, et al. JAMA. 2023 Jul 3;330(1):43-51

Germline genetic testing is recommended by practice guidelines for patients diagnosed with cancer to enable genetically targeted treatment and identify relatives who may benefit from personalized cancer screening and prevention. A... Read More